Sarcopenia, Obesity, or Both. What is the dominant Variable of the Associated Risks of Sarcopenic Obesity?
Innovation in Aging · 16.05.2025 · 9 (5)
DOI: 10.1093/geroni/igaf021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovation in Aging, online erschienen am 28.03.2025. Verfasst von Alejandro Álvarez-Bustos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and objective Sarcopenic obesity (SO), obesity, and sarcopenia have been related to adverse events in older adults, raising the question about the role of each component in the risk associated with SO. The objective of this manuscript is to evaluate the role of sarcopenia, obesity, and its interaction in the risks (frailty, disability, mortality) associated with sarcopenic obesity. Research Design and Methods Data from the Toledo Study of Healthy Aging (TSHA) were used. This is a cohort-based study composed of community-dwelling adults ≥65 years. Obesity (Body Mass Index-BMI ≥30) and sarcopenia (the Foundation for the National Institutes of Health-FNIH criteria, standardized to our population) were assessed at baseline. Frailty, through the Frailty Phenotype (FP) and the Frailty Trait scale-5 (FTS5), and disability (Katz Index) were evaluated at baseline. Mortality, frailty, and disability were assessed at follow-up. Logistic (odds ratio, OR) and Cox (hazard ratio, HR) regression models were computed to assess the associations. Results A total of 1 538 (74.73 years, 45.51% men) individuals were included. Cross-sectionally, SO, sarcopenia, and obesity were significantly associated with the risk of frailty and disability. Longitudinally, Sarcopenia was associated with all the adverse events (ORs/HRs ranged from 1.41 to 4.14, p-value < .05); whereas SO [FP, OR (95% confidence interval—CI): 4.27 (2.05, 8.93); FTS5, OR (95% CI): 6.14 (3.58, 10.51), p-value < .001] and obesity [FP, OR (95% CI): 3.10 (1.95, 4.94), p-value < 0.001; FTS5, OR (95% CI): 2.26 (1.17, 4.35), p-value 0.015] was only associated with incident frailty. Sarcopenia added risk to obesity for frailty (FP and FTS5) whereas obesity only did for frailty (FTS5) in sarcopenic individuals. The interaction between sarcopenia and obesity was not associated with any outcome. Discussion and Implications Sarcopenia and obesity provide each other an additive risk for frailty, but not a multiplicative (ie, interaction) one, in sarcopenic obesity. Sarcopenia is the mean factor accounting for the associated risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
- Instituto de Investigación IdiPaz, Madrid, Spain.
- Fundación de Investigación Biomédica, Hospital Universitario de Getafe, Getafe, Spain.
- Faculty of Health and Social Sciences, Universidad de Las Americas, Santiago, Chile.
- Hospital Universitario de La Princesa, Madrid, Spain.
- Servicio de Geriatría, Hospital Virgen del Valle, Toledo, Spain.
ORCID-Profile: Leocadio Rodríguez-Mañas
Zitieren
APA
Álvarez-Bustos, A., Carnicero, J. A., Sepúlveda-Loyola, W., Molina-Baena, B., Garcia-Garcia, F. J., & Rodríguez-Mañas, L. (2025). Sarcopenia, Obesity, or Both. What is the dominant Variable of the Associated Risks of Sarcopenic Obesity?. Innovation in Aging, 9(5). https://doi.org/10.1093/geroni/igaf021
Vancouver
Álvarez-Bustos A, Carnicero JA, Sepúlveda-Loyola W, Molina-Baena B, Garcia-Garcia FJ, Rodríguez-Mañas L. Sarcopenia, Obesity, or Both. What is the dominant Variable of the Associated Risks of Sarcopenic Obesity?. Innovation in Aging. 2025;9(5). doi:10.1093/geroni/igaf021
BibTeX
@article{lvarezBustos2025,
author = {Álvarez-Bustos, Alejandro and Carnicero, Jose A and Sepúlveda-Loyola, Walter and Molina-Baena, Begoña and Garcia-Garcia, Francisco J and Rodríguez-Mañas, Leocadio},
title = {Sarcopenia, Obesity, or Both. What is the dominant Variable of the Associated Risks of Sarcopenic Obesity?},
journal = {Innovation in Aging},
year = {2025},
volume = {9},
number = {5},
doi = {10.1093/geroni/igaf021}
}
EUVIMED